<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Chemotherapy agents commonly used for heated intraperitoneal chemotherapy&lt;SUP&gt;[1,2]&lt;/SUP&gt;</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Chemotherapy agents commonly used for heated intraperitoneal chemotherapy<sup>[1,2]</sup></h1>
<div class="graphic"><div class="figure"><div class="ttl">Chemotherapy agents commonly used for heated intraperitoneal chemotherapy<sup>[1,2]</sup></div><div class="cntnt"><table cellspacing="0"><colgroup span="5" width="14%"></colgroup><colgroup width="30%"></colgroup> <tbody> <tr> <td class="subtitle1">Class</td> <td class="subtitle1">Chemotherapy</td> <td class="subtitle1">Carrier solution</td> <td class="subtitle1">Area under curve (AUC) ratio*</td> <td class="subtitle1">Tissue penetration (mm)</td> <td class="subtitle1">Adverse effects</td> </tr> <tr class="divider_bottom"> <td class="divider_bottom" rowspan="3"><strong>Platinum-based chemotherapy</strong></td> <td>Cisplatin</td> <td>0.9% sodium chloride</td> <td class="centered">7.8</td> <td class="centered">1 to 3</td> <td> <ul> <li>Nephrotoxicity </li> <li>Peripheral neuropathy </li> <li>Myelotoxicity </li> </ul> </td> </tr> <tr class="divider_bottom"> <td>Oxaliplatin</td> <td>5% dextrose</td> <td class="centered">16</td> <td class="centered">1 to 2</td> <td> <ul> <li>Thrombocytopenia </li> <li>Intraperitoneal hemorrhage </li> <li>Electrolyte disturbances (hyponatremia, hyperglycemia) </li> </ul> </td> </tr> <tr class="divider_bottom"> <td>Carboplatin</td> <td>0.9% sodium chloride</td> <td class="centered">18</td> <td class="centered">1</td> <td> <ul> <li>Postoperative nausea </li> <li>Thrombocytopenia </li> </ul> </td> </tr> <tr> <td rowspan="4"><strong>Non-platinum-based chemotherapy</strong></td> <td class="divider_bottom">Mitomycin <br/> (alkylating tumor antibiotic)</td> <td class="divider_bottom">1.5% dextrose dialysis solution</td> <td class="centered divider_bottom">23.5</td> <td class="centered divider_bottom">2</td> <td class="divider_bottom"> <ul> <li>Neutropenia </li> <li>Nephrotoxicity </li> <li>Interstitial lung disease (dose-dependent) </li> </ul> </td> </tr> <tr class="divider_bottom"> <td>Doxorubicin<br/> (anthracycline antibiotic)</td> <td>1.5% dextrose dialysis solution</td> <td class="centered">230</td> <td class="centered">4 to 6</td> <td> <ul> <li>Cardiotoxicity (arrhythmias) </li> <li>Myelotoxicity </li> </ul> </td> </tr> <tr class="divider_bottom"> <td>Paclitaxel</td> <td>1.5% dextrose dialysis; 6% hetastarch</td> <td class="centered">1000</td> <td class="centered">N/A</td> <td> <ul> <li>Polyneuropathy </li> </ul> </td> </tr> <tr> <td>Flurorouracil</td> <td>0.9% sodium chloride</td> <td class="centered">280</td> <td class="centered">0.2</td> <td> <ul> <li>Polyneuropathy, cardiotoxicity </li> </ul> </td> </tr> </tbody></table></div><div class="graphic_footnotes">N/A: not applicable.<br/>* Concentrations of chemotherapy agents in the peritoneal cavity and the plasma are typically described by the AUC created by plotting the drug concentration over time. The ratio of the peritoneal to plasma AUC is a measure of the degree to which a drug is absorbed. A high AUC ratio is desirable in order to maximize cytotoxicity, while minimizing systemic toxicity. However, a high AUC ratio is only one factor that enters into the choice of intraperitoneal chemotherapy agent, along with efficacy of the drug for the tumor type.</div><div class="graphic_reference">References:

	<ol>
<li>Goodman MD, McPartland S, Detelich D, Said MW. Chemotherapy for intraperitoneal use: a review of hyperthermic intraperitoneal chemotherapy and early post-operative intraperitoneal chemotherapy. J Gastrointest Oncol 2016; 7:45.</li>
<li>de Bree E, Michelakis D, Stamatiou D, et al. Pharmacological principles of intraperitoneal and bidirectional chemotherapy. Pleura Peritoneum 2017; 2:47.</li>
</ol></div><div id="graphicVersion">Graphic 129409 Version 3.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
